Abstract
Tumor Necrosis Factor antagonists (TNFa) are used to manage a multitude of autoimmune disorders like rheumatoid arthritis, inflammatory bowel disease, and others. Etanercept in particular has been studied as a potential therapy for patients with heart failure, but recent evidence suggests that TNFa
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
